Trade Summary

2 weeks ago, Stetz Gary S., serving as Interim CEO at Hepion Pharmaceuticals, Inc. (HEPA), purchased 1,250,000 shares at $0.04 per share, for a total transaction value of $50,000.00. Following this transaction, Stetz Gary S. now holds 1,250,000 shares of HEPA.

The trade was executed on Tuesday, April 21, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 27, 2026, 6 days after the trade was made.

Hepion Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.